Please assess the completion status of the following clinical trial:

Trial Title: Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low Vision

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DEVICE_FEASIBILITY
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
INCLUSION CRITERIA:~To participate in the screening portion of this study, an individual must meet all of the following criteria:~1. Have a diagnosis or suspected diagnosis of any genetically based condition causing low vision to the level specified in criteria 2.~   If the genetic condition is CLN3-related, the individual must have one of the following:~  * a. Two CLN3 pathogenic variants, OR~  * b. One CLN3 pathogenic variant AND~     * i. clinical presentation suggestive of CLN3, OR~    * ii. characteristic electron microscopy (EM) findings (such as curvilinear body, fingerprint profile, granular osmiophilic deposits).~2. Have an estimated visual acuity in the better seeing eye \< 20/200, without the use of an assistive or augmentative device.~3. Is between 6 to 18 years of age.~To participate in the intervention/device use portion of this study, an individual must meet the above screening criteria and the following criteria:~* Have an appropriate cognitive developmental ability to participate based on Investigators screening assessment.~EXCLUSION CRITERIA:~An individual who meets any of the following criteria will be excluded from participation in this study:~* Has any of the following auditory dysfunctions: non-reversible or non-correctable hearing loss, tinnitus that is chronic or occurring daily, auditory hallucinations that occur daily.~* Uses an optic-to-audio assistive device at the time or within 3 months of screening and enrollment.~* Is unable to travel to the NIH because of medical condition for required in-person portions of the study.~* Is unable to comply with or have medical conditions that would potentially increase the risk of participation.

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Children with CLN3 disease (Type: EXPERIMENTAL): Children with CLN3 use the OrCam MyEye 2, a 22.5-g portable, eyeglass-mounted device that converts camera-captured inputs to auditory outputs for text reading, facial recognition, and product identification. The study participants and parents/guardians were trained on how to use the device.
- Children with Low vision without CLN3 (Type: EXPERIMENTAL): Children with low vision not related to CLN3 use the OrCam MyEye 2, a 22.5-g portable, eyeglass-mounted device that converts camera-captured inputs to auditory outputs for text reading, facial recognition, and product identification. The study participants and parents/guardians were trained on how to use the device.

Based on this trial design, predict the completion outcome and termination type (if applicable).